Murali Janakiram, MD, MS, is a hematologist-oncologist and associate professor of medicine at City of Hope National Medical Center in Duarte, California. His clinical expertise is in multiple myeloma and aggressive lymphomas and his research interests include cellular and immune-based therapies (including chimeric antigen receptor [CAR] T-cell therapy and natural killer [NK] cell therapy) and developing risk-based approaches for the treatment of multiple myeloma.
Dr. Janakiram is a clinical trialist and investigator with over 50 peer-reviewed publications, reviews, and book chapters. Before joining City of Hope, he was an assistant professor at the University of Minnesota, where he made significant contributions to T-cell lymphoma and adult T-cell leukemia/lymphoma.
Dr. Janakiram earned his medical degree from Madras Medical College in Chennai, India. He completed an internship and residency in internal medicine at Case Western Reserve University and a fellowship in oncology/hematology at the Albert Einstein College of Medicine, where he also received a master's degree in clinical research.
